Cadrenal Therapeutics, Inc. Common Stock Profile Avatar - Palmy Investing

Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patien…

Biotechnology
US, Ponte Vedra [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of CVKD's Analysis
CIK: 1937993 CUSIP: - ISIN: US1276361086 LEI: - UEI: -
Secondary Listings
CVKD has no secondary listings inside our databases.